|
|
| Research article summary (published 30 Aug 1986): |
Psychiatric diagnosis and behavioral characteristics of phenylketonuric children.
Full Abstract
This study evaluated the psychiatric characteristics and the behavioral effects of an acute load of phenylalanine on phenylketonuric children. The sample consisted of 13 normal-IQ children who were identified at birth as having phenylketonuria and were subsequently treated with a strict low phenylalanine diet. After baseline measurements, the subjects were loaded with placebo or phenylalanine following a double-blind design. Behavioral and metabolic variables were monitored at hourly intervals for five subsequent hours. The effects of acute loading were measured by changes in a standardized Continuous Performance Task (CPT). Psychiatric symptoms were compiled through a structured psychiatric interview of the child and the parent. Results demonstrated that phenylalanine loading, compared to placebo, caused a nonsignificant decrement in performance on CPT testing. Psychiatric disorders were found in six of the 13 subjects with three currently meeting criteria for attention deficit disorder (ADD). In addition, six other subjects were diagnosed in the past as having ADD using DSM-III criteria.
Author information
Author/s: Realmuto, G M (GM); Garfinkel, B D (BD); Tuchman, M (M); Tsai, M Y (MY); Chang, P N (PN); Fisch, R O (RO); Shapiro, S (S);
Journal and publication information
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
Journal: The Journal of nervous and mental disease (J Nerv Ment Dis), published in UNITED STATES. (Language: eng)
Reference: 1986-Sep; vol 174 (issue 9) : pp 536-40
Dates: Created 1986/10/22; Completed 1986/10/22; Revised 2004/11/17;
PMID: 3746280, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: Placebos (0) ; Phenylalanine (63-91-2)Related articles
These are the most related articles currently in our database:
- Timing is everything: executive functions in children exposed to elevated levels of phenylalanine.
29 Jun 2003 - Valine, isoleucine, and leucine. A new treatment for phenylketonuria.
29 Apr 1990 - Neuropsychological effects of subsequent exposure to phenylalanine in adolescents and young adults with early-treated phenylketonuria.
29 Sep 1995 - Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.
29 Jun 1996 - Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
29 Jun 1997 - Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.
30 Jan 1998 - [Phenylketonuria: a children's disease in adulthood]
30 Dec 1999 - [Case studies of the effect of tyrosine administration in children with phenylketonuria on cognitive processes]
30 Oct 1992 - A treatment program for adolescents with phenylketonuria.
30 May 1992
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.